[Pharmacotherapy to control agitation in patients with cognitive deficits].
Agitation is a difficult problem to manage when patients suffer from cognitive impairment of varied etiology. In this article, the author proposes a combination of trazodone and tryptophan as a therapeutic possibility. The author presents an illustrative case. The patient was a 67 year old woman with a left cerebrovascular accident and a global aphasia who presented behaviour problems: she was restless, agitated, noisy, aggressive, screaming, howling and crying. In spite of treatment with neuroleptic, anxiolytic and antidepressive medication, behaviour did not improve. The use of a combination of trazodone and tryptophan was successful.
Hottin
P
P
Département de psyciatrie, Université de Sherbrooke, Québec.
D000368:Aged; D001037:Aphasia / Q000150:complications*; D002544:Cerebral Infarction / Q000150:complications*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000523:psychology; D014196:Trazodone / Q000008:administration & dosage*; D014364:Tryptophan / Q000008:administration & dosage*
D014364:Tryptophan; D014196:Trazodone
Pharmacothérapie pour contrôler l'agitaton chez les patients ayant des déficits cognitifs.